First Food and Drug Administration-Approved Prospective Trial of Primary Intracranial Stenting for Acute Stroke
Elad I. Levy(Kaleida Health), J Mocco(Icahn School of Medicine at Mount Sinai), David Fiorella(Stony Brook University Hospital), Kenneth V. Snyder(Kaleida Health), L. Nelson Hopkins(The University of Western Australia), Annemarie Crumlish(Kaleida Health), Erik F. Hauck(Kaleida Health), Adnan H. Siddiqui(Jacobs (United States))
Cited by 301
Related Papers
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke
|New England Journal of Medicine|2015|5.1k
Stenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
|New England Journal of Medicine|2010|3k
Stenting versus Aggressive Medical Therapy for Intracranial Arterial Stenosis
|New England Journal of Medicine|2011|1.9k